难治性肺结核咯血的临床诊疗方法分析

摘要

目的：在深入探究难治性肺结核咯血的临床诊疗方法的基础上，进一步分析提升难治性肺结核咯血患者临床诊疗效果的方法。方法以随机方式选择本院2013年6月～2015年6月收取的23例难治性肺结核咯血患者（A组），选择莫西沙星为治疗药物；同期选取22例难治性肺结核咯血患者（B组），选择常规疗法，综合对比两组入选患者治疗情况。结果 A组入选患者有效率95.65%，B组68.18%；A组止血时长（2.00±0.21）d，B组（5.73±0.78）d，P＜0.05，差异具有统计学意义。结论基于难治性肺结核咯血患者，选择莫西沙星为治疗药物除了安全性高以外，还能缩短止血时长。%Objective To explore the clinical diagnosis and treatment method of refractory pulmonary tuberculosis hemoptysis, on the basis of further analysis method enhance clinical diagnosis and treatment effect of refractory pulmonary tuberculosis hemoptysis patients.Methods Selected 23 cases of refractory pulmonary tuberculosis hemoptysis patients (group A) in our hospital from June 2013 to June 2015 in our hospital randomly, selected the same period of 22 cases of refractory pulmonary tuberculosis hemoptysis patients (group B), choose the conventional therapy, comprehensive comparison in patients of two groups treatment.Results The group A patients effective rate was 95.65%, 68.18% in group B, A group of selected patients stop bleeding duration (2.00±0.21) day, group B (5.73±0.78) day,P<0.05, had difference statistically significance.Conclusion Based on the intractable tuberculosis hemoptysis patients, choose moxilfoxacin for drugs in addition to high safety, can shorten the patients stop bleeding time, can be promoted.